Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
50.72B | 50.77B | 36.33B | 27.56B | 22.29B | 26.68B | Gross Profit |
4.76B | 4.49B | 3.14B | 3.15B | 2.17B | 3.19B | EBIT |
422.38M | 260.25M | -75.33M | 204.05M | -437.56M | 44.36M | EBITDA |
1.25B | 1.29B | 274.59M | 1.32B | 611.38M | 1.02B | Net Income Common Stockholders |
368.10M | 312.33M | -704.78M | 254.30M | -329.74M | 80.82M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
6.07B | 5.71B | 4.84B | 2.67B | 3.48B | 3.25B | Total Assets |
37.91B | 37.23B | 36.49B | 23.83B | 22.59B | 22.98B | Total Debt |
6.30B | 5.51B | 5.67B | 1.43B | 1.48B | 1.37B | Net Debt |
231.00M | -194.75M | 834.72M | -1.24B | -2.00B | -1.88B | Total Liabilities |
23.78B | 23.05B | 23.57B | 10.58B | 9.70B | 9.67B | Stockholders Equity |
14.06B | 14.11B | 12.86B | 13.18B | 12.83B | 13.26B |
Cash Flow | Free Cash Flow | ||||
0.00 | 1.26B | -972.85M | -980.21M | -81.64M | -2.03B | Operating Cash Flow |
0.00 | 1.84B | -316.85M | -502.21M | 774.36M | -787.45M | Investing Cash Flow |
0.00 | -602.67M | -587.92M | -118.10M | -381.37M | -1.06B | Financing Cash Flow |
0.00 | -357.39M | 2.96B | -238.00M | -85.44M | -525.21M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | $3.02T | 8.26 | 6.77% | 5.30% | 1.42% | -27.64% | |
73 Outperform | $168.50B | 7.82 | 10.08% | 3.46% | -11.02% | -21.84% | |
71 Outperform | ¥4.21B | 12.38 | 2.13% | -0.54% | ― | ||
70 Outperform | ¥212.09B | 7.28 | 6.56% | 4.88% | -0.91% | 80.48% | |
66 Neutral | $155.45B | 11.52 | 6.92% | 6.27% | 2.48% | -18.92% | |
66 Neutral | $1.02T | 11.77 | 3.62% | 5.08% | -4.62% | -30.09% | |
50 Neutral | $1.98B | -1.06 | -21.29% | 3.61% | 1.95% | -30.60% |